<code id='9EED6C9981'></code><style id='9EED6C9981'></style>
    • <acronym id='9EED6C9981'></acronym>
      <center id='9EED6C9981'><center id='9EED6C9981'><tfoot id='9EED6C9981'></tfoot></center><abbr id='9EED6C9981'><dir id='9EED6C9981'><tfoot id='9EED6C9981'></tfoot><noframes id='9EED6C9981'>

    • <optgroup id='9EED6C9981'><strike id='9EED6C9981'><sup id='9EED6C9981'></sup></strike><code id='9EED6C9981'></code></optgroup>
        1. <b id='9EED6C9981'><label id='9EED6C9981'><select id='9EED6C9981'><dt id='9EED6C9981'><span id='9EED6C9981'></span></dt></select></label></b><u id='9EED6C9981'></u>
          <i id='9EED6C9981'><strike id='9EED6C9981'><tt id='9EED6C9981'><pre id='9EED6C9981'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:43119
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          The problems with dementia villages
          The problems with dementia villages

          AdobeRecently,dementiavillageshavegainedpopularityinEuropeandAustraliaasanall-in-onesolutiontocaring

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Roivant's CEO is a star, but biotech's black hole persists

          MollyFerguson/STATRoivantSciences’MattGlinemightbethisyear’sbestbiopharmaCEO,andotherthoughtsaboutMo